Campus alert status is yellow: For the latest campus alert status, news and resources, visit umassmed.edu/coronavirus

Search Close Search
Search Close Search
Page Menu

Dr. David Harlan Spoke at the American Diabetes Association's Virtual Scientific Sessions | "100 Years of Insulin - A Medical Marvel: The Past, Present & Future"

david-harlan-nicole-johnson-american-diabetes-association.png

July 2021 will be the 100th anniversary of Banting & Best isolating the insulin hormone to develop a life-saving treatment for millions of people worldwide.  In the following video, this distinguished panel of experts will take you on a journey through the history of insulin, the current state of insulin therapy, and what's on the horizon. 

Nicole Johnson

VP of Operations, Science and Healthcare, American Diabetes Association

This online program was hosted by Nicole Johnson, the 1999 Miss America winner.  Since being diagnosed with type 1 diabetes (T1D) in 1993, she's been an advocate and role model for people living with T1D.  Nicole is one of many UMass Diabetes Center of Excellence (DCOE) Wall of Honor patient success stories and is always willing to share her experience to inspire others.  She's also a long-standing member of the UMass DCOE Visiting Advocacy Committee

David M. Harlan, MD

William and Doris Krupp Professor of Medicine and Co-Director, Diabetes Center of Excellence, University of Massachusetts Medical School

Dr. Harlan is acclaimed worldwide as a diabetes researcher & endocrinologist who has been laser focused on a single goal during his 35 year career - to put an end to insulin dependent diabetes.  In the following video, he explains the history of insulin and the many people who've played important roles in its development and improvements.  You'll learn the special role that insulin research has played in biomedical advances and medical history.  

Robert A. Gabbay, MD, PhD

Chief Scientific and Medical Officer, American Diabetes Association

Dr. Gabbay talks about the current state of insulin to treat diabetes.  He describes how far we've come from boiling syringes and sharpening them on stones, to the insulin pens and insulin pumps used today.  He also describes what's ahead on the clinical frontier with the development of ultra-fast, ultra-long and ultra-stable insulins. 

Michael A. Weiss, MD, PhD

Chair, Biochemistry & Molecular Biology, Indiana University School of Medicine

Dr. Weiss spoke about how insulin and diabetes treatment can be improved using device-driven protein engineering which could allow scientists to match the speed and precision of normal beta cell pancreatic insulin release.

#Insulin100 - A Medical Marvel: Let's Talk Insulin Past, Present & Future

American Diabetes Association Virtual Scientific Sessions, June 2021

David Harlan and Nicole Johnson Type 1 Diabetes

The Harlan & Greiner Labs Developed a New Method to Study Human Cells and Tissue to Improve Type 1 Diabetes Research

Modeling Type 1 Diabetes Using Human Stem Cells in the Brehm & Greiner Labs


Dr. Harlan Presents "Going Beyond Insulin in Type 1 Diabetes" at the Endocrine Society's Annual Fellows Conference

 

Insulin Access and Affordability Issues Are Affecting UMass Diabetes Patients and People Nationwide


More Diabetes Center of Excellence News